Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Prostate Cancer Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Prostate Cancer Diagnostics Market Perspective (2016-2027)
2.2 Prostate Cancer Diagnostics Growth Trends by Regions
2.2.1 Prostate Cancer Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prostate Cancer Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Prostate Cancer Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Prostate Cancer Diagnostics Industry Dynamic
2.3.1 Prostate Cancer Diagnostics Market Trends
2.3.2 Prostate Cancer Diagnostics Market Drivers
2.3.3 Prostate Cancer Diagnostics Market Challenges
2.3.4 Prostate Cancer Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Diagnostics Players by Revenue
3.1.1 Global Top Prostate Cancer Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Prostate Cancer Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Diagnostics Revenue
3.4 Global Prostate Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Prostate Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics Revenue in 2020
3.5 Prostate Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Prostate Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Diagnostics Breakdown Data by Type
4.1 Global Prostate Cancer Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Prostate Cancer Diagnostics Forecasted Market Size by Type (2022-2027)

5 Prostate Cancer Diagnostics Breakdown Data by Application
5.1 Global Prostate Cancer Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Prostate Cancer Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Prostate Cancer Diagnostics Market Size (2016-2027)
6.2 North America Prostate Cancer Diagnostics Market Size by Type
6.2.1 North America Prostate Cancer Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Prostate Cancer Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Prostate Cancer Diagnostics Market Size by Type (2016-2027)
6.3 North America Prostate Cancer Diagnostics Market Size by Application
6.3.1 North America Prostate Cancer Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Prostate Cancer Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Prostate Cancer Diagnostics Market Size by Application (2016-2027)
6.4 North America Prostate Cancer Diagnostics Market Size by Country
6.4.1 North America Prostate Cancer Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Prostate Cancer Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Prostate Cancer Diagnostics Market Size (2016-2027)
7.2 Europe Prostate Cancer Diagnostics Market Size by Type
7.2.1 Europe Prostate Cancer Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Prostate Cancer Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Prostate Cancer Diagnostics Market Size by Type (2016-2027)
7.3 Europe Prostate Cancer Diagnostics Market Size by Application
7.3.1 Europe Prostate Cancer Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Prostate Cancer Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Prostate Cancer Diagnostics Market Size by Application (2016-2027)
7.4 Europe Prostate Cancer Diagnostics Market Size by Country
7.4.1 Europe Prostate Cancer Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Prostate Cancer Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Prostate Cancer Diagnostics Market Size by Type
8.2.1 Asia-Pacific Prostate Cancer Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prostate Cancer Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prostate Cancer Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Prostate Cancer Diagnostics Market Size by Application
8.3.1 Asia-Pacific Prostate Cancer Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prostate Cancer Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prostate Cancer Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Prostate Cancer Diagnostics Market Size by Region
8.4.1 Asia-Pacific Prostate Cancer Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prostate Cancer Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Prostate Cancer Diagnostics Market Size (2016-2027)
9.2 Latin America Prostate Cancer Diagnostics Market Size by Type
9.2.1 Latin America Prostate Cancer Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Prostate Cancer Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Prostate Cancer Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Prostate Cancer Diagnostics Market Size by Application
9.3.1 Latin America Prostate Cancer Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Prostate Cancer Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Prostate Cancer Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Prostate Cancer Diagnostics Market Size by Country
9.4.1 Latin America Prostate Cancer Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Prostate Cancer Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Prostate Cancer Diagnostics Market Size by Type
10.2.1 Middle East & Africa Prostate Cancer Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prostate Cancer Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prostate Cancer Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Prostate Cancer Diagnostics Market Size by Application
10.3.1 Middle East & Africa Prostate Cancer Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prostate Cancer Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prostate Cancer Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Prostate Cancer Diagnostics Market Size by Country
10.4.1 Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 OPKO
11.1.1 OPKO Company Details
11.1.2 OPKO Business Overview
11.1.3 OPKO Prostate Cancer Diagnostics Introduction
11.1.4 OPKO Revenue in Prostate Cancer Diagnostics Business (2016-2021)
11.1.5 OPKO Recent Development
11.2 Genomic Health
11.2.1 Genomic Health Company Details
11.2.2 Genomic Health Business Overview
11.2.3 Genomic Health Prostate Cancer Diagnostics Introduction
11.2.4 Genomic Health Revenue in Prostate Cancer Diagnostics Business (2016-2021)
11.2.5 Genomic Health Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Prostate Cancer Diagnostics Introduction
11.3.4 Abbott Revenue in Prostate Cancer Diagnostics Business (2016-2021)
11.3.5 Abbott Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Details
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Prostate Cancer Diagnostics Introduction
11.4.4 Beckman Coulter Revenue in Prostate Cancer Diagnostics Business (2016-2021)
11.4.5 Beckman Coulter Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Details
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Prostate Cancer Diagnostics Introduction
11.5.4 Siemens Healthcare Revenue in Prostate Cancer Diagnostics Business (2016-2021)
11.5.5 Siemens Healthcare Recent Development
11.6 bioMeriux
11.6.1 bioMeriux Company Details
11.6.2 bioMeriux Business Overview
11.6.3 bioMeriux Prostate Cancer Diagnostics Introduction
11.6.4 bioMeriux Revenue in Prostate Cancer Diagnostics Business (2016-2021)
11.6.5 bioMeriux Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Prostate Cancer Diagnostics Introduction
11.7.4 Roche Revenue in Prostate Cancer Diagnostics Business (2016-2021)
11.7.5 Roche Recent Development
11.8 MDx Health
11.8.1 MDx Health Company Details
11.8.2 MDx Health Business Overview
11.8.3 MDx Health Prostate Cancer Diagnostics Introduction
11.8.4 MDx Health Revenue in Prostate Cancer Diagnostics Business (2016-2021)
11.8.5 MDx Health Recent Development
11.9 DiaSorin
11.9.1 DiaSorin Company Details
11.9.2 DiaSorin Business Overview
11.9.3 DiaSorin Prostate Cancer Diagnostics Introduction
11.9.4 DiaSorin Revenue in Prostate Cancer Diagnostics Business (2016-2021)
11.9.5 DiaSorin Recent Development
11.10 Myriad Genetics
11.10.1 Myriad Genetics Company Details
11.10.2 Myriad Genetics Business Overview
11.10.3 Myriad Genetics Prostate Cancer Diagnostics Introduction
11.10.4 Myriad Genetics Revenue in Prostate Cancer Diagnostics Business (2016-2021)
11.10.5 Myriad Genetics Recent Development
11.11 Ambry Genetics
11.11.1 Ambry Genetics Company Details
11.11.2 Ambry Genetics Business Overview
11.11.3 Ambry Genetics Prostate Cancer Diagnostics Introduction
11.11.4 Ambry Genetics Revenue in Prostate Cancer Diagnostics Business (2016-2021)
11.11.5 Ambry Genetics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Prostate Cancer Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tumor Biomarker Tests
Table 3. Key Players of Imaging
Table 4. Key Players of Biopsy
Table 5. Key Players of Other
Table 6. Global Prostate Cancer Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Prostate Cancer Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Prostate Cancer Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Prostate Cancer Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Prostate Cancer Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Prostate Cancer Diagnostics Market Share by Regions (2022-2027)
Table 12. Prostate Cancer Diagnostics Market Trends
Table 13. Prostate Cancer Diagnostics Market Drivers
Table 14. Prostate Cancer Diagnostics Market Challenges
Table 15. Prostate Cancer Diagnostics Market Restraints
Table 16. Global Prostate Cancer Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Prostate Cancer Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Prostate Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Diagnostics as of 2020)
Table 19. Ranking of Global Top Prostate Cancer Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Prostate Cancer Diagnostics Product Solution and Service
Table 23. Date of Enter into Prostate Cancer Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prostate Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Prostate Cancer Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Prostate Cancer Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Prostate Cancer Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Prostate Cancer Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Prostate Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Prostate Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Prostate Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Prostate Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Prostate Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Prostate Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Prostate Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Prostate Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Prostate Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Prostate Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Prostate Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Prostate Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Prostate Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Prostate Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Prostate Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Prostate Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Prostate Cancer Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Prostate Cancer Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Prostate Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Prostate Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Prostate Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Prostate Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Prostate Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Prostate Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Prostate Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Prostate Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Prostate Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Prostate Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Prostate Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. OPKO Company Details
Table 64. OPKO Business Overview
Table 65. OPKO Prostate Cancer Diagnostics Product
Table 66. OPKO Revenue in Prostate Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 67. OPKO Recent Development
Table 68. Genomic Health Company Details
Table 69. Genomic Health Business Overview
Table 70. Genomic Health Prostate Cancer Diagnostics Product
Table 71. Genomic Health Revenue in Prostate Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Genomic Health Recent Development
Table 73. Abbott Company Details
Table 74. Abbott Business Overview
Table 75. Abbott Prostate Cancer Diagnostics Product
Table 76. Abbott Revenue in Prostate Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Abbott Recent Development
Table 78. Beckman Coulter Company Details
Table 79. Beckman Coulter Business Overview
Table 80. Beckman Coulter Prostate Cancer Diagnostics Product
Table 81. Beckman Coulter Revenue in Prostate Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Beckman Coulter Recent Development
Table 83. Siemens Healthcare Company Details
Table 84. Siemens Healthcare Business Overview
Table 85. Siemens Healthcare Prostate Cancer Diagnostics Product
Table 86. Siemens Healthcare Revenue in Prostate Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Siemens Healthcare Recent Development
Table 88. bioMeriux Company Details
Table 89. bioMeriux Business Overview
Table 90. bioMeriux Prostate Cancer Diagnostics Product
Table 91. bioMeriux Revenue in Prostate Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 92. bioMeriux Recent Development
Table 93. Roche Company Details
Table 94. Roche Business Overview
Table 95. Roche Prostate Cancer Diagnostics Product
Table 96. Roche Revenue in Prostate Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Roche Recent Development
Table 98. MDx Health Company Details
Table 99. MDx Health Business Overview
Table 100. MDx Health Revenue in Prostate Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 101. MDx Health Recent Development
Table 102. DiaSorin Company Details
Table 103. DiaSorin Business Overview
Table 104. DiaSorin Prostate Cancer Diagnostics Product
Table 105. DiaSorin Revenue in Prostate Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 106. DiaSorin Recent Development
Table 107. Myriad Genetics Company Details
Table 108. Myriad Genetics Business Overview
Table 109. Myriad Genetics Prostate Cancer Diagnostics Product
Table 110. Myriad Genetics Revenue in Prostate Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 111. Myriad Genetics Recent Development
Table 112. Ambry Genetics Company Details
Table 113. Ambry Genetics Business Overview
Table 114. Ambry Genetics Prostate Cancer Diagnostics Product
Table 115. Ambry Genetics Revenue in Prostate Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 116. Ambry Genetics Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Tumor Biomarker Tests Features
Figure 3. Imaging Features
Figure 4. Biopsy Features
Figure 5. Other Features
Figure 6. Global Prostate Cancer Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Age Below 55 Case Studies
Figure 8. Age 55-75 Case Studies
Figure 9. Age Above 75 Case Studies
Figure 10. Prostate Cancer Diagnostics Report Years Considered
Figure 11. Global Prostate Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Prostate Cancer Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Prostate Cancer Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Prostate Cancer Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Prostate Cancer Diagnostics Market Share by Players in 2020
Figure 16. Global Top Prostate Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics Revenue in 2020
Figure 18. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Prostate Cancer Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Prostate Cancer Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Prostate Cancer Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Prostate Cancer Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Prostate Cancer Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Prostate Cancer Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Prostate Cancer Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Prostate Cancer Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Prostate Cancer Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Prostate Cancer Diagnostics Market Share by Region (2016-2027)
Figure 40. China Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Prostate Cancer Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Prostate Cancer Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Prostate Cancer Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Prostate Cancer Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Prostate Cancer Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Prostate Cancer Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Prostate Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. OPKO Revenue Growth Rate in Prostate Cancer Diagnostics Business (2016-2021)
Figure 60. Genomic Health Revenue Growth Rate in Prostate Cancer Diagnostics Business (2016-2021)
Figure 61. Abbott Revenue Growth Rate in Prostate Cancer Diagnostics Business (2016-2021)
Figure 62. Beckman Coulter Revenue Growth Rate in Prostate Cancer Diagnostics Business (2016-2021)
Figure 63. Siemens Healthcare Revenue Growth Rate in Prostate Cancer Diagnostics Business (2016-2021)
Figure 64. bioMeriux Revenue Growth Rate in Prostate Cancer Diagnostics Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Prostate Cancer Diagnostics Business (2016-2021)
Figure 66. MDx Health Revenue Growth Rate in Prostate Cancer Diagnostics Business (2016-2021)
Figure 67. DiaSorin Revenue Growth Rate in Prostate Cancer Diagnostics Business (2016-2021)
Figure 68. Myriad Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Business (2016-2021)
Figure 69. Ambry Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed